ISU Specialty Chemical

At a glance

ISU Specialty Chemical filed 60 disclosures in the last 12 months, including 10 5% holder and 6 insider. The most recent key filing was on Oct 26: A major holder's stake fell from 35.33% to 35.29% (conversion/exercise).

Revenue for 2025 was ₩411B, up 23.9% on 2024. Operating margin was 0.4% against 4.3% a year earlier. Debt was 176% of equity at year end. The latest interim report (2026 H1) shows revenue of ₩217B and operating profit of ₩11.2B.

The 2025 annual report lists 277 employees with an average tenure of 2.2 years and average pay of ₩93.6M, #204 of 1,829 listed companies by average pay. Its 5 directors and auditors were paid ₩248M each on average. It paid no cash dividend for 2025. ㈜이수 and related parties held 35.45% at year end.

Of 1 recent 5%+ holder report, 0 raised and 1 cut a stake; the largest stake reported was 35.29% on Oct 26.

From the 2025 annual report

Staff: 277 (245 men, 32 women), of whom 25 on fixed-term contracts. Total pay for the year: ₩26B. Directors and auditors: 5, paid ₩1.2B in total.

No cash dividend was paid for 2025.

Largest shareholder

㈜이수 holds 25.04%; with 7 related parties the group holds 35.45% of common shares at year end.

Individuals paid ₩500M or more

Auditor: 삼정회계법인 · opinion: Unqualified.

Source: 2025 annual business report (DART). How figures are combined

Financial summary

5%+ holder reports